Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

137.26 +0.06 (+0.04%)
Streaming Delayed Price Updated: 11:39 AM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
37 38 Next >
Bank Stocks Will Keep Underperforming, It’s The Business Cycle
Bank stocks respond to changes in the business cycle and not to interest rates. 
Via Talk Markets
Weekly Market Pulse - Monday, April 18
It may be time to go contrarian. In this interview, I talk about stocks, bonds & commodities. 
Via Talk Markets
Leading And Lagging Sectors For April 13, 2022
Gainers Symbol Name Price Change ($) Change (%) Volume 
Via Benzinga
5 ETFs That Gained Investors Love Last Week
Here are the ETFs that dominated the top creation list last week. 
Via Talk Markets
Healthcare Stocks Lead the Way Up as the Market Fades
With inflation and energy costs soaring, the Fed ever threatening with higher rates and headlines from the war in Ukraine investors are seeking more defensive positions. 
Via Talk Markets
Defensives Propping Up New Highs
To cap off last week, a net 11% of S&P 500 stocks were at new 52-week highs; the highest reading since January 5th which was only a couple of days after the index’s last all-time high. 
Via Talk Markets
AskSlim Market Week - Friday, April 8
Technical and cycle analysis, and market commentary. 
Via Talk Markets
2 ETFs Show Flight To Safety
The Health Care Select Sector SPDR Fund ETF (NYSE: XLV) has been ripping higher, while the Technology Select Sector SPDR Fund ETF (NYSE: XLK) has been getting crushed. 
Via Benzinga
Back to the Middle of the Middle Ahead of Financial Earnings Next Week
We continue to see the market caught in the 
Via Talk Markets
Sector Price and Breadth Update
Utilities, Consumer Staples, and Energy are seeing their AD lines pull back from new highs, but price has been somewhat disconnected. 
Via Talk Markets
This Sorta-Rebound Is Starting To Separate Sectors, It Could Be A Big Deal
Despite the pullback late last week, stocks are back in bulls mode. 
Via Talk Markets
Will This Year’s Red-Hot Run For US Energy Stocks Continue?
Energy stocks are enjoying the mother of all upside outlier performances for US equity sectors this year. 
Via Talk Markets
Sizing Sectors
After peaks in S&P 500® concentration, the S&P 500 Equal Weight Index has tended to outperform, suggesting that there is a relationship between changes in concentration and the relative performance of... 
Via Talk Markets
Biotech Funds and ETFs Continue to Lag
It’s no secret that market sectors driving inflation are leading the market. With the US economy still strong and the War in Ukraine limiting supply of nat gas and raw materials, producer costs are... 
Via Talk Markets
Equity Income Whitepaper
Inflation has reached levels not seen in 40 years, pressuring the Federal Reserve to raise interest rates and reduce their balance sheet. 
Via Talk Markets
Leading And Lagging Sectors For March 23, 2022
Gainers Symbol Name Price 
Via Benzinga
How do Biotechnology Funds and ETFs Perform Over Five Years?
Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV. 
Via Talk Markets
Market Recap - An impressive rally
The S&P 500 has rallied 6.9% over the past four days. The rally is impressive, but we're still not out of the woods. 
Via Talk Markets
Style Perspectives In Vogue
U.S. equities have had a tough start to the year amid rising inflation concerns, anticipated rate hikes by the Federal Reserve, earnings misses from several mega-cap companies, and ongoing geopolitical... 
Via Talk Markets
No Easy Answer: Sector and Factor Responses to U.S. Rate Hikes
Although higher rates are generally seen as negative for risk assets, the initial stages of a monetary tightening cycle have not been disastrous for the U.S. stock market historically. 
Via Talk Markets
Tough Slogging Ahead for Investors, Diversification is Important
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows. 
Via Talk Markets
The Ukraine War And The Stock Market News
Focusing on the underlying trends and big trend changes remains the cornerstone to successful investing and trading. Big news events are not changing this nor having as big of a change on the trends as... 
Via Talk Markets
Weekly Market Pulse: Oil Shock
A strong dollar is not something we generally think of as a negative for the US economy but a rapidly rising one can create problems for countries and companies with outstanding dollar debts. 
Via Talk Markets
Fear & Greed Have Become Best Friends
It has been another bumpy week for the market. One day the market was down -1.5%, followed by a quick +2.5% bounce, only to again retreat with several days of continued selling to finish the week. 
Via Talk Markets
Russia/Ukraine Conflict and Implications on Sector Views
For positioning, investors should be ready for volatility as events unfold and focus on more defensive sectors of the economy. 
Via Talk Markets
Value Stock Outperformance Might Continue
Growth stock investors are willing to pay a higher price for a company's stock where its earnings are growing at a high rate. 
Via Talk Markets
Two Volatile Sectors
The volatility of the Information Technology and Consumer Discretionary sectors increased by 2% and 3%, respectively, while the volatility of the remaining sectors was either flat or down. 
Via Talk Markets
Leading And Lagging Sectors For February 17, 2022
Gainers Symbol Name Pr... 
Via Benzinga
One of These Sectors Is Not Like the Others
While most sectors are firmly in the red on a year-to-date basis, Energy has rallied over 25%, and it’s only mid-February. 
Via Talk Markets
Large Cap Biopharma- Well Positioned For Choppy Markets
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets. 
Via Talk Markets
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.